S2Medical AB (publ) (S2M.ST)

SEK 0.01

(4.55%)

Net Debt Summary of S2Medical AB (publ)

  • S2Medical AB (publ)'s latest annual net debt in 2023 was -1.51 Million SEK , up 59.25% from previous year.
  • S2Medical AB (publ)'s latest quarterly net debt in 2024 Q2 was -1.37 Million SEK , up 0.29% from previous quarter.
  • S2Medical AB (publ) reported annual net debt of -3.72 Million SEK in 2022, up 59.84% from previous year.
  • S2Medical AB (publ) reported annual net debt of -9.27 Million SEK in 2021, up 61.87% from previous year.
  • S2Medical AB (publ) reported quarterly net debt of -1.37 Million SEK for 2024 Q2, up 0.29% from previous quarter.
  • S2Medical AB (publ) reported quarterly net debt of -1.49 Million SEK for 2023 Q3, up 9.93% from previous quarter.

Annual Net Debt Chart of S2Medical AB (publ) (2023 - 2015)

Historical Annual Net Debt of S2Medical AB (publ) (2023 - 2015)

Year Net Debt Net Debt Growth
2023 -1.51 Million SEK 59.25%
2022 -3.72 Million SEK 59.84%
2021 -9.27 Million SEK 61.87%
2020 -24.31 Million SEK -74.26%
2019 -13.95 Million SEK 59.21%
2018 -34.2 Million SEK -542.16%
2017 -5.32 Million SEK -170.63%
2016 -1.96 Million SEK -229.96%
2015 1.51 Million SEK 0.0%

Peer Net Debt Comparison of S2Medical AB (publ)

Name Net Debt Net Debt Difference
AddLife AB (publ) 5.01 Billion SEK 100.03%
Biotage AB (publ) -444 Million SEK 99.658%
Bonesupport Holding AB (publ) -149.86 Million SEK 98.988%
Doxa AB (publ) -102.2 Million SEK 98.516%
Elekta AB (publ) 4.46 Billion SEK 100.034%
iZafe Group AB (publ) -2.65 Million SEK 42.947%
Ortivus AB (publ) 4.19 Million SEK 136.189%
Ortivus AB (publ) 4.19 Million SEK 136.189%
Q-linea AB (publ) -61.33 Million SEK 97.526%
Synsam AB (publ) 2.67 Billion SEK 100.057%